Gastroenterology
Volume 137, Issue 2 , Pages 629-638 , August 2009

Reduced Level of Smoothened Suppresses Intestinal Tumorigenesis by Down-Regulation of Wnt Signaling

Received 19 November 2008 ,Accepted 27 April 2009.

References 

  1. Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 2001;15:3059–3087
  2. van den Brink GR. Hedgehog signaling in development and homeostasis of the gastrointestinal tract. Physiol Rev. 2007;87:1343–1375
  3. Lum L, Beachy PA. The Hedgehog response network: sensors, switches, and routers. Science. 2004;304:1755–1759
  4. Rubin LL, de Sauvage FJ. Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov. 2006;5:1026–1033
  5. Oniscu A, James RM, Morris RG, et al. Expression of Sonic hedgehog pathway genes is altered in colonic neoplasia. J Pathol. 2004;203:909–917
  6. Douard R, Moutereau S, Pernet P, et al. Sonic Hedgehog-dependent proliferation in a series of patients with colorectal cancer. Surgery. 2006;139:665–670
  7. Monzo M, Moreno I, Artells R, et al. Sonic hedgehog mRNA expression by real-time quantitative PCR in normal and tumor tissues from colorectal cancer patients. Cancer Lett. 2006;233:117–123
  8. Yauch RL, Gould SE, Scales SJ, et al. Paracrine requirement for hedgehog signalling in cancer. Nature. 2008;18:406–410
  9. Qualtrough D, Buda A, Gaffield W, et al. Hedgehog signalling in colorectal tumour cells: induction of apoptosis with cyclopamine treatment. Int J Cancer. 2004;110:831–837
  10. Zhu Y, James RM, Peter A, et al. Functional Smoothened is required for expression of GLI3 in colorectal carcinoma cells. Cancer Lett. 2004;207:205–214
  11. van den Brink GR, Bleuming SA, Hardwick JCH, et al. Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation. Nat Genet. 2004;36:277–282
  12. Madison BB, Braunstein K, Kuizon E, et al. Epithelial hedgehog signals pattern the intestinal crypt-villus axis. Development. 2005;132:279–289
  13. Chatel G, Ganeff C, Boussif N, et al. Hedgehog signaling pathway is inactive in colorectal cancer cell lines. Int J Cancer. 2007;121:2622–2627
  14. Taketo MM. Wnt signaling and gastrointestinal tumorigenesis in mouse models. Oncogene. 2006;25:7522–7530
  15. Oshima M, Oshima H, Kitagawa K, et al. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci U S A. 1995;92:4482–4486
  16. Takaku K, Oshima M, Miyoshi H, et al. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell. 1998;92:645–656
  17. Zhang XM, Ramalho-Santos M, McMahon AP. Smoothened mutants reveal redundant roles for Shh and Ihh signaling including regulation of L/R symmetry by the mouse node. Cell. 2001;106:781–792
  18. Fujishita T, Aoki K, Lane HA, et al. Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcΔ716 mice. Proc Natl Acad Sci U S A. 2008;105:13544–13549
  19. Sasaki H, Hui C, Nakafuku M, et al. A binding site for Gli proteins is essential for HNF-3β floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development. 1997;124:1313–1322
  20. Oshima M, Oshima H, Matsunaga A, et al. Hyperplastic gastric tumors with spasmolytic peptide-expressing metaplasia (SPEM) caused by TNF-α-dependent inflammation in COX-2/mPGES-1 transgenic mice. Cancer Res. 2005;65:9147–9151
  21. Gayet J, Zhou XP, Duval A, et al. Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene. 2001;20:5025–5032
  22. Ilyas M, Tomlinson IPM, Rowan A, et al. β-Catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci U S A. 1997;94:10330–10334
  23. Gao J, Li Z, Chen Z, et al. Antisense Smo under the control of the PTCH1 promoter delivered by an adenoviral vector inhibits the growth of human pancreatic cancer. Gene Ther. 2006;13:1587–1594
  24. Stecca B, Mas C, Clement V, et al. Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc Natl Acad Sci U S A. 2007;104:5895–5900
  25. Berman DM, Karhadkar SS, Maitra A, et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumors. Nature. 2003;425:846–851
  26. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8:387–398
  27. Petrova TV, Nykänen A, Norrmén C, et al. Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. Cancer Cell. 2008;13:407–419
  28. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509–1512
  29. Szeto W, Jiang W, Tice DA, et al. Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid. Cancer Res. 2001;61:4197–4205
  30. Arnold SJ, Stappert J, Bauer A, et al. Brachyury is a target gene of the Wnt/β-catenin signaling pathway. Mech Dev. 2000;91:249–258
  31. Mao J, Ligon KL, Rakhlin EY, et al. A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. Cancer Res. 2006;66:10171–10178
  32. Dakubo GD, Mazerolle CJ, Wallace VA. Expression of Notch and Wnt pathway components and activation of Notch signaling in medulloblastomas from heterozygous patched mice. J Neurooncol. 2006;79:221–227
  33. Guleng B, Tateishi K, Ohta M, et al. Smoothened gene mutations found in digestive cancer have no aberrant Hedgehog signaling activity. J Gastroenterol. 2006;41:1238–1239
  34. Hoseong Yang S, Andl T, Grachtchouk V, et al. Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/β-catenin signaling. Nat Genet. 2008;40:1030–1035
  35. Akiyoshi T, Nakamura M, Koga K, et al. Gli1, down-regulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation. Gut. 2006;55:991–999
  36. Staal FJ, Noort Mv M, Strous GJ, et al. Wnt signals are transmitted through N-terminally dephosphorylated β-catenin. EMBO Rep. 2002;3:63–68
  37. van Noort M, van de Wetering M, Clevers H. Identification of two novel regulated serines in the N terminus of β-catenin. Exp Cell Res. 2002;276:264–272
  38. Hendriksen J, Fagotto F, van der Velde H, et al. RanBP3 enhances nuclear export of active (β)-catenin independently of CRM1. J Cell Biol. 2005;171:785–797

 M.A. and M.M.T. are senior authors.

 A.M.'s current address is Burnham Institute for Medical Research, La Jolla, California.

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by Grants-in-Aid of Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M.M.T.).

PII: S0016-5085(09)00739-2

doi: 10.1053/j.gastro.2009.04.059

Gastroenterology
Volume 137, Issue 2 , Pages 629-638 , August 2009

Article Tools

* Image Usage & Resolution